| 1 | Survey of liver pathologists to assess attitudes towards digital pathology and artificial intelligence | 1.3 | 12 | Citations (PDF) |
| 2 | An End-to-End Platform for Digital Pathology Using Hyperspectral Autofluorescence Microscopy and Deep Learning-Based Virtual Histology | 3.8 | 21 | Citations (PDF) |
| 3 | Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease | 10.3 | 46 | Citations (PDF) |
| 4 | Steatohepatitic hepatocellular Carcinoma:A new approach to classifying morphological subtypes of hepatocellular carcinoma | 1.7 | 5 | Citations (PDF) |
| 5 | Severe acute liver disease in adults: Contemporary role of histopathology | 2.6 | 12 | Citations (PDF) |
| 6 | AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases | 22.6 | 45 | Citations (PDF) |
| 7 | Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? | 10.3 | 186 | Citations (PDF) |
| 8 | The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis | 0.9 | 197 | Citations (PDF) |
| 9 | COVID-19 and liver cancer: lost patients and larger tumours | 1.3 | 29 | Citations (PDF) |
| 10 | The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis | 0.9 | 150 | Citations (PDF) |
| 11 | A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC? | 2.7 | 34 | Citations (PDF) |
| 12 | The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study | 1.7 | 23 | Citations (PDF) |
| 13 | Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma | 0.2 | 2 | Citations (PDF) |
| 14 | Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease | 6.7 | 184 | Citations (PDF) |
| 15 | Drug-Induced Hepatocellular Injury Due to Herbal Supplement Ashwagandha | 0.5 | 26 | Citations (PDF) |
| 16 | Narrow-band imaging for scar (NBI-SCAR) classification: from conception to multicenter validation | 1.0 | 12 | Citations (PDF) |
| 17 | Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon | 1.8 | 57 | Citations (PDF) |
| 18 | The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease | 1.1 | 129 | Citations (PDF) |
| 19 | Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease | 0.7 | 15 | Citations (PDF) |
| 20 | A transcriptomic signature predicting fibrosis progression in a large European cohort of patients with histologically characterised NAFLD | 6.7 | 0 | Citations (PDF) |
| 21 | Comparison of different virtual chromoendoscopy classification systems for the characterization of colorectal lesions | 0.9 | 14 | Citations (PDF) |
| 22 | Computer-aided diagnosis for characterization of colorectal lesions: comprehensive software that includes differentiation of serrated lesions | 1.0 | 50 | Citations (PDF) |
| 23 | Learning curve for mastery of colorectal endoscopic submucosal dissection: Perspectives from a large Japanese cohort | 0.9 | 13 | Citations (PDF) |
| 24 | Deep learning uncertainty and confidence calibration for the five-class polyp classification from colonoscopy | 9.3 | 66 | Citations (PDF) |
| 25 | Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ | 6.7 | 461 | Citations (PDF) |
| 26 | Fifty years of impact on liver pathology: a history of the Gnomes | 1.9 | 3 | Citations (PDF) |
| 27 | Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment | 2.7 | 14 | Citations (PDF) |
| 28 | The degree of hepatic steatosis associates with impaired cardiac and autonomic function | 6.7 | 70 | Citations (PDF) |
| 29 | Cancer-associated fibroblasts in gastrointestinal cancer | 33.1 | 536 | Citations (PDF) |
| 30 | Effect of time of day and specialty on polyp detection rates in Australia | 1.8 | 17 | Citations (PDF) |
| 31 | Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR) | 2.6 | 48 | Citations (PDF) |
| 32 | Cellular senescence drives age-dependent hepatic steatosis | 10.8 | 998 | Citations (PDF) |
| 33 | Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity | 30.6 | 566 | Citations (PDF) |
| 34 | Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial | 5.0 | 201 | Citations (PDF) |
| 35 | Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis | 0.7 | 850 | Citations (PDF) |
| 36 | A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis | 1.5 | 52 | Citations (PDF) |
| 37 | Columnar Metaplasia in the Esophageal Remnant After Esophagectomy | 3.4 | 14 | Citations (PDF) |
| 38 | Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma | 4.1 | 20 | Citations (PDF) |
| 39 | DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival | 4.5 | 82 | Citations (PDF) |
| 40 | Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management | 6.7 | 1,003 | Citations (PDF) |
| 41 | Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification | 2.0 | 134 | Citations (PDF) |
| 42 | Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease | 6.7 | 114 | Citations (PDF) |
| 43 | Pathology of the liver sinusoids | 2.6 | 74 | Citations (PDF) |
| 44 | Clinical but not histological factors predict long‐term prognosis in patients with histologically advanced non‐decompensated alcoholic liver disease | 3.1 | 40 | Citations (PDF) |
| 45 | A reversible model for periportal fibrosis and a refined alternative to bile duct ligation | 1.4 | 11 | Citations (PDF) |
| 46 | TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease | 10.8 | 575 | Citations (PDF) |
| 47 | Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma | 6.7 | 532 | Citations (PDF) |
| 48 | White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers | 1.7 | 31 | Citations (PDF) |
| 49 | 520 TRANSPLANTATION FOR ALD: LESSONS FROM THE EXPLANT | 6.7 | 0 | Citations (PDF) |
| 50 | Identification of a neuronal transcription factor network involved in
medulloblastoma development | 3.3 | 42 | Citations (PDF) |
| 51 | Adult human exocrine pancreas differentiation to hepatocytes – potential source of a human hepatocyte progenitor for use in toxicology research | 1.4 | 10 | Citations (PDF) |
| 52 | Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease | 9.6 | 111 | Citations (PDF) |
| 53 | 74 APPLICATION, UTILITY AND VALIDATION OF A NEW HISTOLOGICAL SYSTEM FOR CLASSIFICATION OF NAFLD IN PATIENTS WITH METABOLIC SYNDROME | 6.7 | 0 | Citations (PDF) |
| 54 | Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model | 6.7 | 108 | Citations (PDF) |
| 55 | Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser | 2.2 | 17 | Citations (PDF) |
| 56 | 1368 FURTHER VALIDATION OF TERMINAL PEPTIDE OF PROCOLLAGEN III (PIIINP) FOR THE DETECTION AND ASSESSMENT OF NONALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE | 6.7 | 0 | Citations (PDF) |
| 57 | 1275 CARRIAGE OF PNPLA3 I148M IS ASSOCIATED WITH AN INCREASED RISK OF NON-ALCOHOLIC FATTY LIVER DIESEASE ASSOCIATED HEPATOCELLULAR CARCINOMA | 6.7 | 7 | Citations (PDF) |
| 58 | Development of a robust protocol for gene expression analysis using formalin-fixed, paraffin-embedded liver transplant biopsy specimens | 1.3 | 2 | Citations (PDF) |
| 59 | Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels? | 1.1 | 87 | Citations (PDF) |
| 60 | Inhibition of RelA-Ser536 Phosphorylation by a Competing Peptide Reduces Mouse Liver Fibrosis Without Blocking the Innate Immune Response | 9.6 | 42 | Citations (PDF) |
| 61 | Cholestase bei jungen Männern nach Anabolika-Einnahme | 0.2 | 0 | Citations (PDF) |
| 62 | Cholestasis secondary to anabolic steroid use in young men | 0.1 | 31 | Citations (PDF) |
| 63 | Multigenerational epigenetic adaptation of the hepatic wound-healing response | 22.6 | 271 | Citations (PDF) |
| 64 | Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis | 1.7 | 208 | Citations (PDF) |
| 65 | Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease | 9.6 | 62 | Citations (PDF) |
| 66 | Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation | 9.6 | 127 | Citations (PDF) |
| 67 | Liver cell dysplasia and early hepatocellular carcinoma | 0.4 | 0 | Citations (PDF) |
| 68 | Lymph Node Metastasis in Early Esophageal Adenocarcinoma | 3.4 | 62 | Citations (PDF) |
| 69 | Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease | 22.6 | 208 | Citations (PDF) |
| 70 | ORTHOTOPIC LIVER TRANSPLANTATION: CORRELATION BETWEEN STRESS-INDUCED SENESCENCE AND EPITHELIAL TO MESENCHYMAL TRANSITION OF THE BILIARY EPITHELIUM? | 1.4 | 0 | Citations (PDF) |
| 71 | the C-Rel Subunit of Nuclear Factor-κB Regulates Murine Liver Inflammation, Wound-Healing, and Hepatocyte Proliferation | 9.6 | 57 | Citations (PDF) |
| 72 | T Cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection | 1.6 | 11 | Citations (PDF) |
| 73 | Elevated endotoxin levels in non-alcoholic fatty liver disease | 3.1 | 352 | Citations (PDF) |
| 74 | Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease | 10.3 | 304 | Citations (PDF) |
| 75 | Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease | 10.3 | 846 | Citations (PDF) |
| 76 | Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease | 10.3 | 168 | Citations (PDF) |
| 77 | Results of a Two-Center Study Comparing Hepatic Fibrosis Progression in HCV-positive Liver Transplant Patients Receiving Cyclosporine or Tacrolimus | 0.5 | 9 | Citations (PDF) |
| 78 | Disrupted Pancreatic Exocrine Differentiation and Malabsorption in Response to Chronic Elevated Systemic Glucocorticoid | 2.8 | 20 | Citations (PDF) |
| 79 | 704 IDENTIFICATION OF CANDIDATE GENES IN DIET INDUCED NON-ALCOHOLIC FATTY LIVER DISEASE IN INBRED MICE | 6.7 | 0 | Citations (PDF) |
| 80 | 1001 CYTOCHOME P450 2E1 (CYP2E1) AUTOREACTIVITY IN ALCOHOLIC LIVER DISEASE: NO EVIDENCE FOR A PATHOGENETIC ROLE | 6.7 | 0 | Citations (PDF) |
| 81 | Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers | 9.6 | 676 | Citations (PDF) |
| 82 | Ontogeny of human intrahepatic innervation | 1.9 | 13 | Citations (PDF) |
| 83 | Epithelial to mesenchymal transition in primary sclerosing cholangitis | 3.1 | 6 | Citations (PDF) |
| 84 | Mutations in CHD7 in patients with CHARGE syndrome cause T–B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome | 2.3 | 117 | Citations (PDF) |
| 85 | Fibrosis and Cirrhosis Reversibility – Molecular Mechanisms | 2.2 | 78 | Citations (PDF) |
| 86 | Liver fibrosis | 2.3 | 288 | Citations (PDF) |
| 87 | Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance | 10.3 | 191 | Citations (PDF) |
| 88 | The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD | 9.6 | 2,964 | Citations (PDF) |
| 89 | Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis | 9.6 | 150 | Citations (PDF) |
| 90 | Pathology of liver tumours | 0.2 | 2 | Citations (PDF) |
| 91 | The diffuse stellate cell system | 1.5 | 76 | Citations (PDF) |
| 92 | Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease | 1.8 | 221 | Citations (PDF) |
| 93 | Alcoholic liver disease | 1.8 | 149 | Citations (PDF) |
| 94 | Late Humoral Rejection in a Compliant ABO-compatible Liver Transplant Recipient | 1.4 | 38 | Citations (PDF) |
| 95 | Chronic Allograft Nephropathy: Intraepithelial Signals Generated by Transforming Growth Factor-β and Bone Morphogenetic Protein-7 | 3.4 | 41 | Citations (PDF) |
| 96 | Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: effects of platelet-derived growth factor and extracellular nucleotides | 1.8 | 12 | Citations (PDF) |
| 97 | Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation | 1.3 | 16 | Citations (PDF) |
| 98 | Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients | 2.4 | 313 | Citations (PDF) |
| 99 | Mast cells and c-Kit expression in liver allograft rejection | 2.6 | 23 | Citations (PDF) |
| 100 | A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis | 2.5 | 3 | Citations (PDF) |
| 101 | Study of Apoptosis and Heat Shock Protein (HSP) Expression in Hepatocytes Following Radiofrequency Ablation (RFA) | 1.0 | 75 | Citations (PDF) |
| 102 | Chronic Renal Allograft Dysfunction | 0.2 | 116 | Citations (PDF) |
| 103 | Spectrum of liver pathology in immune mediated liver diseases | 1.8 | 1 | Citations (PDF) |
| 104 | Monitoring methotrexate‐induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified? | 2.7 | 111 | Citations (PDF) |
| 105 | Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma | 0.4 | 73 | Citations (PDF) |
| 106 | Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse | 9.6 | 28 | Citations (PDF) |
| 107 | Serum markers detect the presence of liver fibrosis: A cohort study | 0.9 | 1,047 | Citations (PDF) |
| 108 | The sentinel node concept in the metastatic dissemination of esophageal adenocarcinoma | 0.9 | 0 | Citations (PDF) |
| 109 | Metastatic breast carcinoma presenting as acute liver failure and portal hypertension | 0.7 | 17 | Citations (PDF) |
| 110 | Familial primary biliary cirrhosis and autoimmune cholangitis | 2.0 | 6 | Citations (PDF) |
| 111 | Primary biliary cirrhosis and other ductopenic diseases | 2.2 | 38 | Citations (PDF) |
| 112 | Investigation of a Mechanism for Accelerated Breakdown of Immune Tolerance to the Primary Biliary Cirrhosis–Associated Autoantigen, Pyruvate Dehydrogenase Complex | 1.8 | 29 | Citations (PDF) |
| 113 | Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex | 9.6 | 48 | Citations (PDF) |
| 114 | Metastatic breast carcinoma presenting as acute liver failure and portal hypertension | 0.7 | 0 | Citations (PDF) |
| 115 | Relationship between TGFβ1, intratubular CD103 positive T cells and acute renal allograft rejection | 0.5 | 6 | Citations (PDF) |
| 116 | TGF-β expression in protocol transplant liver biopsies: a comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression | 0.5 | 7 | Citations (PDF) |
| 117 | TUBULITIS AFTER RENAL TRANSPLANTATION: DEMONSTRATION OF AN ASSOCIATION BETWEEN CD103+ T CELLS, TRANSFORMING GROWTH FACTOR ??1 EXPRESSION AND REJECTION GRADE 1 | 1.4 | 63 | Citations (PDF) |
| 118 | Managing chronic hepatitis C acquired through intravenous drug use | 0.3 | 45 | Citations (PDF) |
| 119 | Overexpression of HER2/neu in solid tumours: an immunohistochemical survey | 2.6 | 146 | Citations (PDF) |
| 120 | The role of phosphatidic acid in platelet-derived growth factor-induced proliferation of rat hepatic stellate cells | 9.6 | 26 | Citations (PDF) |
| 121 | Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy | 3.1 | 34 | Citations (PDF) |
| 122 | Presentation and mortality of primary biliary cirrhosis in older patients | 1.2 | 26 | Citations (PDF) |
| 123 | Ulcerative colitis: An investigation of the potential role played by AEB7 +ve T-cells | 0.9 | 0 | Citations (PDF) |
| 124 | Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture | 6.7 | 74 | Citations (PDF) |
| 125 | Pathobiology of hepatic stellate cells | 3.0 | 51 | Citations (PDF) |
| 126 | Composition of the Pulmonary Interstitium during Normal Development of the Human Fetus | 0.8 | 19 | Citations (PDF) |
| 127 | Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol | 1.0 | 19 | Citations (PDF) |
| 128 | Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis | 9.6 | 103 | Citations (PDF) |
| 129 | Primary biliary cirrhosis once rare, now common in the United Kingdom? | 9.6 | 218 | Citations (PDF) |
| 130 | Macrophage and hepatic stellate cell responses during experimental hepatocarcinogenesis | 1.8 | 16 | Citations (PDF) |
| 131 | Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C | 9.6 | 209 | Citations (PDF) |
| 132 | Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration | 3.2 | 60 | Citations (PDF) |
| 133 | Hepatitis G virus does not cause significant liver disease after liver transplantation | 1.3 | 15 | Citations (PDF) |
| 134 | Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major | 26.5 | 399 | Citations (PDF) |
| 135 | Heterozygotes for
HFE
mutations have no increased risk of advanced alcoholic liver disease | 10.3 | 88 | Citations (PDF) |
| 136 | Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer | 10.3 | 26 | Citations (PDF) |
| 137 | Outcome of post-transfusion hepatitis C: disease severity in blood- component recipients and their implicated donors | 0.3 | 15 | Citations (PDF) |
| 138 | Autoimmune hepatitis in older patients | 1.2 | 61 | Citations (PDF) |
| 139 | Characterisation of the DNA repair enzyme for O6-methylguanine in cirrhosis | 6.7 | 16 | Citations (PDF) |
| 140 | Intra-observer variation in the histopathological assessment of chronic viral hepatitis | 6.7 | 160 | Citations (PDF) |
| 141 | Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis | 6.7 | 142 | Citations (PDF) |
| 142 | Cushing's syndrome secondary to ectopic ACTH secretion from a primary ovarian carcinoma | 1.5 | 14 | Citations (PDF) |
| 143 | Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis | 9.6 | 19 | Citations (PDF) |
| 144 | Hepatic allograft rejection: Regulation of the immunogenicity of human intrahepatic biliary epithelial cells | 3.0 | 13 | Citations (PDF) |
| 145 | CD44 IS EXPRESSED IN HEPATOCELLULAR CARCINOMAS SHOWING VASCULAR INVASION 1996, 179, 74-79 | | 57 | Citations (PDF) |
| 146 | TRANSFORMING GROWTH FACTOR-α EXPRESSION IS ALTERED DURING EXPERIMENTAL HEPATOCARCINOGENESIS 1996, 179, 276-282 | | 21 | Citations (PDF) |
| 147 | Hepatitis C virus: epidemiology and genotypes in the north east of England. | 10.3 | 62 | Citations (PDF) |
| 148 | Non-Hodgkin's Lymphoma and Hepatitis C Virus Infection | 1.0 | 63 | Citations (PDF) |
| 149 | Cellular distribution of androgen receptors in the liver. | 1.3 | 16 | Citations (PDF) |
| 150 | Innervation of the liver: morphology and function | 0.0 | 61 | Citations (PDF) |
| 151 | Intrahepatic mast cells in chronic liver diseases | 9.6 | 93 | Citations (PDF) |
| 152 | The natural history of nonalcoholic fatty liver: A follow-up study | 9.6 | 877 | Citations (PDF) |
| 153 | Methylprednisolone does not inhibit the nonparenchymal cell responses to dimethylnitrosamine-induced liver injury | 0.5 | 0 | Citations (PDF) |
| 154 | Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules | 6.7 | 50 | Citations (PDF) |
| 155 | Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver | 46.9 | 472 | Citations (PDF) |
| 156 | Intrahepatic mast cells in chronic liver diseases*1 | 9.6 | 107 | Citations (PDF) |
| 157 | The natural history of nonalcoholic fatty liver: A follow-up study | 9.6 | 81 | Citations (PDF) |
| 158 | Post-infantile giant cell hepatitis: histological and immunohistochemical study. | 1.3 | 52 | Citations (PDF) |
| 159 | Expression of mutant p53 protein in hepatocellular carcinoma. | 10.3 | 20 | Citations (PDF) |
| 160 | Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis | 2.6 | 35 | Citations (PDF) |
| 161 | Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury | 6.7 | 33 | Citations (PDF) |
| 162 | A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis | 1.8 | 46 | Citations (PDF) |
| 163 | Intrahepatic distribution of transforming growth factor-alpha (TGFα) during liver regeneration following carbon tetrachlorideinduced necrosis | 3.2 | 46 | Citations (PDF) |
| 164 | Cellular and molecular aspects of hepatic fibrosis | 3.2 | 130 | Citations (PDF) |
| 165 | Bile duct proliferation?its true significance? | 2.6 | 50 | Citations (PDF) |
| 166 | Pathology of alcoholic liver disease | 1.4 | 12 | Citations (PDF) |
| 167 | Morphologic Investigation of Sinusoidal Cells | 2.0 | 58 | Citations (PDF) |
| 168 | Plasma Membrane Form of Phosphatidate Phosphohydrolase: A Possible Role in Signal Transduction during Liver Fibrogenesis | 4.1 | 7 | Citations (PDF) |
| 169 | CD30 expression by peripheral blood monocytes and hepatic macrophages in a child with miliary tuberculosis. | 1.3 | 9 | Citations (PDF) |
| 170 | Disappearance of hepatic parenchymal nerves in human liver cirrhosis. | 10.3 | 48 | Citations (PDF) |
| 171 | Glutathione S-transferases in neonatal liver disease. | 1.3 | 17 | Citations (PDF) |
| 172 | c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma | 6.7 | 55 | Citations (PDF) |
| 173 | Liver fibrosis. | 0.1 | 7 | Citations (PDF) |
| 174 | Macrophage and perisinusoidal cell kinetics in acute liver injury | 3.2 | 119 | Citations (PDF) |
| 175 | Hepatic reinnervation following orthotopic liver transplantation in man | 3.2 | 42 | Citations (PDF) |
| 176 | Immunolocalization of proliferating perisinusoidal cells in rat liver | 0.2 | 23 | Citations (PDF) |
| 177 | Light microscopic and ultrastructural distribution of type VI collagen in human liver: alterations in chronic biliary disease | 2.6 | 31 | Citations (PDF) |
| 178 | Nodular regenerative hyperplasia of the liver in Behçet's disease | 2.6 | 10 | Citations (PDF) |
| 179 | Fibrin-ring granulomas: a non-specific reaction to liver injury? | 2.6 | 27 | Citations (PDF) |
| 180 | Basement membrane proteins in the space of Disse: a reappraisal. | 1.3 | 29 | Citations (PDF) |
| 181 | Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia | 2.6 | 79 | Citations (PDF) |
| 182 | Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno-gold labelling | 2.6 | 40 | Citations (PDF) |
| 183 | An abstract machine for the implementation of PARLOG on uniprocessors | 1.2 | 14 | Citations (PDF) |
| 184 | Localization of adrenergic and neuropeptide tyrosine-containing nerves in the mammalian liver | 9.6 | 63 | Citations (PDF) |
| 185 | In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion | 6.7 | 182 | Citations (PDF) |
| 186 | Unusual variant of primary sclerosing cholangitis. | 1.3 | 8 | Citations (PDF) |
| 187 | Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: changes in liver disease. | 1.3 | 24 | Citations (PDF) |
| 188 | Mixed Follicular-Parafollicular Carcinoma of the Thyroid | 1.3 | 9 | Citations (PDF) |
| 189 | Dermoid Cyst of the Testis | 1.3 | 12 | Citations (PDF) |
| 190 | NEUROPEPTIDE Y IN MULTIPLE ENDOCRINE NEOPLASIA: RELEASE DURING SURGERY FOR PHAEOCHROMOCYTOMA | 1.5 | 14 | Citations (PDF) |
| 191 | Prognostic factors in thyroid tumours | 4.1 | 43 | Citations (PDF) |
| 192 | Desmin-containing stellate cells in rat liver; distribution in normal animals and response to experimental acute liver injury | 3.2 | 124 | Citations (PDF) |
| 193 | Histologic Spectrum of Alcoholic Liver Disease | 2.0 | 256 | Citations (PDF) |
| 194 | Fine needle aspiration cytology: experience with a cell block technique. | 1.3 | 19 | Citations (PDF) |
| 195 | The effect of 5-fluorouracil on rat adrenal function | 1.4 | 1 | Citations (PDF) |
| 196 | Breast cancer in women with primary biliary cirrhosis. | 0.1 | 64 | Citations (PDF) |
| 197 | Lymphoid and epithelial markers in small cell anaplastic thyroid tumours. | 1.3 | 20 | Citations (PDF) |
| 198 | The cellular pathology of primary biliary cirrhosis | 7.5 | 21 | Citations (PDF) |
| 199 | Acquired immunodeficiency syndrome in a patient with no known risk factors: a pathological study. | 1.3 | 20 | Citations (PDF) |
| 200 | Thyroglobulin in carcinoma of the thyroid | 1.7 | 4 | Citations (PDF) |
| 201 | Pyrexia of undetermined origin, diarrhoea, and primary cerebral lymphoma associated with acquired immunodeficiency. | 0.1 | 10 | Citations (PDF) |
| 202 | Liver membrane antibodies in alcoholic liver disease: 1. prevalence and immunoglobulin class. | 10.3 | 45 | Citations (PDF) |
| 203 | Rise in Female-Initiated Sexual Activity at Ovulation and Its Suppression by Oral Contraceptives | 26.5 | 216 | Citations (PDF) |
| 204 | Title is missing! 0 | | 1 | Citations (PDF) |
| 205 | Investigating the mechanisms of indocyanine green tumour uptake in sarcoma cell lines and ex vivo human tissue | 3.2 | 6 | Citations (PDF) |
| 206 | Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials | 6.7 | 12 | Citations (PDF) |
| 207 | Head to head: should portal inflammation be part of grading necroinflammatory activity in metabolic dysfunction‐associated steatotic liver disease? | 2.6 | 1 | Citations (PDF) |
| 208 | Fibrosis regression in chronic liver disease: the pathologist’s view | 6.7 | 0 | Citations (PDF) |
